低密度脂蛋白胆固醇主要与存在冠状动脉粥样硬化证据患者的ASCVD事件相关:Western Denmark心脏登记研究
中位随访4.3年,552例发生首次ASCVD事件;LDL-C仅与CAC>0患者的ASCVD相关(aHR 1.18),CAC=0者无关联(aHR 1.02),主要结果在MESA中重复。
要点
- LDL-C升高仅与CAC>0患者的ASCVD事件相关,CAC=0者未见关联。
- CAC=0时糖尿病、当前吸烟和低HDL-C与未来ASCVD事件相关。
- CAC状态有助于中年人群个体化ASCVD风险评估。
核心结论
- 在中位随访约5年内,LDL-C似乎几乎仅与存在冠状动脉粥样硬化证据的中年个体ASCVD事件相关。
研究设计与样本
- 采用Cox回归模型并按基线CAC>0与CAC=0分层,评估CTA前LDL-C与随访ASCVD事件(心肌梗死和缺血性卒中)的关联。
- 主要结果在NHLBI资助的Multi-Ethnic Study of Atherosclerosis中重复验证。
主要发现
- 中位随访4.3年,552例患者发生首次ASCVD事件。
- 总体人群中,LDL-C每增加38.7 mg/dL与ASCVD事件相关(aHR 1.14,95%CI 1.04-1.24)。
- CAC>0患者中,LDL-C>193 mg/dL较<116 mg/dL与ASCVD相关(aHR 2.42,95%CI 1.59-3.67);CAC=0者无关联(aHR 0.92,95%CI 0.48-1.79)。
关键数值与推荐
- LDL-C每增加38.7 mg/dL,总体人群ASCVD的aHR为1.14(95%CI 1.04-1.24)。
- CAC>0者LDL-C每增加38.7 mg/dL的aHR为1.18(95%CI 1.06-1.31),CAC=0者为1.02(95%CI 0.87-1.18)。
- CAC>0者LDL-C>193 mg/dL vs <116 mg/dL的aHR为2.42(95%CI 1.59-3.67),CAC=0者为0.92(95%CI 0.48-1.79)。
临床怎么用
- 对中年症状性患者评估ASCVD风险时,应结合CAC状态解读LDL-C的预测价值。
- CAC=0者LDL-C与短期ASCVD事件关联不明显,需同时关注糖尿病、当前吸烟和低HDL-C等风险因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Low-density lipoprotein cholesterol (LDL-C) is an important causal risk factor for atherosclerotic cardiovascular disease (ASCVD). However, a sizable proportion of middle-aged individuals with elevated LDL-C level have not developed coronary atherosclerosis as assessed by coronary artery calcification (CAC). Whether presence of CAC modifies the association of LDL-C with ASCVD risk is unknown. We evaluated the association of LDL-C with future ASCVD events in patients with and without CAC. METHODS: The study included 23 132 consecutive symptomatic patients evaluated for coronary artery disease using coronary computed tomography angiography (CTA) from the Western Denmark Heart Registry, a seminational, multicenter-based registry with longitudinal registration of patient and procedure data. We assessed the association of LDL-C level obtained before CTA with ASCVD (myocardial infarction and ischemic stroke) events occurring during follow-up stratified by CAC>0 versus CAC=0 using Cox regression models adjusted for baseline characteristics. Outcomes were identified through linkage among national registries covering all hospitals in Denmark. We replicated our results in the National Heart, Lung, and Blood Institute-funded Multi-Ethnic Study of Atherosclerosis. RESULTS: During a median follow-up of 4.3 years, 552 patients experienced a first ASCVD event. In the overall population, LDL-C (per 38.7 mg/dL increase) was associated with ASCVD events occurring during follow-up (adjusted hazard ratio [aHR], 1.14 [95% CI, 1.04-1.24]). When stratified by the presence or absence of baseline CAC, LDL-C was only associated with ASCVD in the 10 792/23 132 patients (47%) with CAC>0 (aHR, 1.18 [95% CI, 1.06-1.31]); no association was observed among the 12 340/23 132 patients (53%) with CAC=0 (aHR, 1.02 [95% CI, 0.87-1.18]). Similarly, a very high LDL-C level (>193 mg/dL) versus LDL-C <116 mg/dL was associated with ASCVD in patients with CAC>0 (aHR, 2.42 [95% CI, 1.59-3.67]) but not in those without CAC (aHR, 0.92 [0.48-1.79]). In patients with CAC=0, diabetes, current smoking, and low high-density lipoprotein cholesterol levels were associated with future ASCVD events. The principal findings were replicated in the Multi-Ethnic Study of Atherosclerosis. CONCLUSIONS: LDL-C appears to be almost exclusively associated with ASCVD events over ≈5 years of follow-up in middle-aged individuals with versus without evidence of coronary atherosclerosis. This information is valuable for individualized risk assessment among middle-aged people with or without coronary atherosclerosis.
引用
- Mortensen MB, Dzaye O, Bøtker HE, et al. Low-Density Lipoprotein Cholesterol Is Predominantly Associated With Atherosclerotic Cardiovascular Disease Events in Patients With Evidence of Coronary Atherosclerosis: The Western Denmark Heart Registry. Circulation. 2023. PMID: 36621817. doi:10.1161/CIRCULATIONAHA.122.061010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。